Special items: Ovarian Cancer and Us blog best viewed in Firefox

▼
Showing posts with label Bevacizumab. Show all posts
Showing posts with label Bevacizumab. Show all posts
Wednesday, July 11, 2012

Cisplatin plus paclitaxel and maintenance of (Avastin) bevacizumab on tumour progression, dissemination, and survival of ovarian carcinoma xenograft models

›
Cisplatin plus paclitaxel and maintenance of bevacizumab on tumour progression, dissemination, and survival of ovarian carcinoma xenograft m...
Monday, May 28, 2012

paywalled: Bevacizumab-induced perforation of the gastrointestinal tract: clinical and radiographic findings in 11 patients

›
Bevacizumab-induced perforation of the gastrointestinal tract: clinical and radiographic findings in 11 patients : Abstract Aim To pr...
Thursday, May 24, 2012

Clinical Care Options - OCEANS: PFS Improvement of 4 Months With the Addition of Bevacizumab to Carboplatin/Gemcitabine in Patients With Platinum-Sensitive Recurrent Ovarian Cancer ASCO 2011

›
 Blogger's Note : requires registration (free) to view Clinical Care Options - Oncology CME - OCEANS: PFS Improvement of 4 Months With...
Monday, May 21, 2012

Roche will report new data on important progress for people with advanced cancers at ASCO 2012 - AURELIA trial ovarian/Avastin+

›
Roche will report new data on important progress for people with advanced cancers at ASCO 2012 Data from AURELIA, the first Phase III stud...
Saturday, May 19, 2012

The role of bevacizumab in advanced epithelial ovarian cancer.

›
The role of bevacizumab in advanced epithelial ovarian cancer. : The role of bevacizumab in advanced epithelial ovarian cancer. Curr P...
Thursday, May 17, 2012

ASCO '12 Abstract Dump: Cancer Stocks in Focus - TheStreet (financial)

›
ASCO '12 Abstract Dump: Cancer Stocks in Focus - TheStreet .....While investors were flooded with new cancer drug data Wednesday, ASC...
Wednesday, May 16, 2012

paywalled: Intraperitoneal and intravenous chemotherapy in peritoneal carcinomatosis.

›
Intraperitoneal and intravenous chemotherapy in peritoneal carcinomatosis. : Intraperitoneal and intravenous chemotherapy in peritoneal...
Tuesday, May 01, 2012

Medscape: Bevacizumab Benefits Patients With Recurrent Ovarian Cancer (bevacizumab plus carboplatin and gemcitabine followed by bevacizumab)

›
Bevacizumab Benefits Patients With Recurrent Ovarian Cancer
Thursday, April 26, 2012

Correspondence: Bevacizumab in Neoadjuvant Treatment for Breast Cancer — NEJM

›
Blogger's Note:   correspondence/author's reply/references; while this is specific to Avastin/breast cancer,  future trial protocols...

PLoS ONE: Effect of Angiogenesis Inhibitor (Avastin) Bevacizumab on Survival in Patients with Cancer: A Meta-Analysis of the Published Literature

›
 Blogger's Note : indicates which cancer patients did/did not show PFS/OS; limited to combo therapies (lack of monotherapy trials); read...
Wednesday, April 25, 2012

Add-on bevacizumab slows progression of recurrent ovarian cancer - - ModernMedicine

›
Add-on bevacizumab slows progression of recurrent ovarian cancer - - ModernMedicine (from Reuters) ".... Dr. Aghajanian and colleagu...

paywalled: Vascular disrupting agents: a delicate balance between efficacy and side (safety) effects

›
Vascular disrupting agents: a delicate balance between effi... : Current Opinion in Oncology Current Opinion in Oncology: May 2012...
Tuesday, April 24, 2012

phase 2: Vargatef (Nintedanib) in Addition to First Line Chemotherapy With Interval Debulking Surgery in Patients With Ovarian Cancer - Full Text View - ClinicalTrials.gov - France) (treatment/placebo/note: Avastin...)

›
Vargatef in Addition to First Line Chemotherapy With Interval Debulking Surgery in Patients With Ovarian Cancer - Full Text View - ClinicalT...

open access: JCO - OCEANS: A Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Chemotherapy With or Without Bevacizumab in Patients With Platinum-Sensitive Recurrent Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

›
OCEANS : A Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Chemotherapy With or Without Bevacizumab in Patients With Plati...
Friday, April 20, 2012

Medscape: (Avastin) Bevacizumab: First-Line Therapy in Ovarian Cancer?: Evidence for First-Line Therapy Dr's Markman, Burger, Swenterton

›
Bevacizumab: First-Line Therapy in Ovarian Cancer?: Evidence for First-Line Therapy Editor’s Note:   Two phase ...
Monday, April 16, 2012

open access: PLoS ONE: Proteins from Avastin® (bevacizumab) Show Tyrosine Nitrations for which the Consequences Are Completely Unclear

›
PLoS ONE: Proteins from Avastin® (bevacizumab) Show Tyrosine Nitrations for which the Consequences Are Completely Unclear "......A ma...
Wednesday, April 11, 2012

abstract: Sequential Bevacizumab and Oral Cyclophosphami... [Gynecol Oncol. 2012] - PubMed - NCBI

›
Sequential Bevacizumab and Oral Cyclophosphamide for Recurrent Ovarian Cancer. Abstract OBJECTIVE: Test the safety and efficacy of...

(first line treatment approved) - New treatment (Avastin) option for ovarian cancer in Australia - News

›
New treatment option for ovarian cancer in Australia - News "Australian women with advanced ovarian cancer have a new treatment opti...
Wednesday, April 04, 2012

further details: FDA MedWatch - Altuzan (bevacizumab): Counterfeit Product - Contains no Active Ingredient

›
Subject: Apr 3rd FDA MedWatch - Altuzan (bevacizumab): Counterfeit Product - Contains no Active Ingredient Altuzan (bevacizumab): Counterf...
Tuesday, April 03, 2012

FDA identifies more bogus cancer drugs (Avastin - labeled as Altuzan) in U.S | Reuters

›
FDA identifies more bogus cancer drugs in U.S | Reuters Tue Apr 3, 2012 8:31pm EDT   (Reuters) - The...